Gut and digestion
Inflammatory bowel disease
Crohn’s disease and ulcerative colitis involve bowel inflammation that can cause bleeding, pain, diarrhoea and nutritional deficits. Symptom relief does not always mean inflammation is controlled.
Potential benefits explored
Calmer bowel inflammation and improved daily function.
KPV and BPC-157 are experimental bowel-repair/inflammation leads. Symptom relief and control of inflammatory disease should be measured separately.
Practical interpretation
Track objective disease activity and maintain appropriate IBD treatment. Address deficiencies and food tolerance with a condition-specific nutrition plan.
Meaningful outcomes: Bleeding, stool frequency and objective disease activity.
Compare the compounds studied for Inflammatory bowel disease
Members see the full evidence picture for this condition: every compound studied, graded per condition from strong human evidence through to preclinical-only and negative findings, with human and animal results, risks, combination evidence and cited sources — plus how each compound maps to the research materials we list, with live pricing and stock.
Research reference for laboratory materials only. Not medical advice and not a recommendation for human use. Research cut-off: 30 September 2026.